Document is current
Any future updates will be listed below
-
Authors
Taylor, Beth A
Zaleski, Amanda L
Dornelas, Ellen A
Thompson, Paul D
- License Information
-
More Information
Article History
Received: 28 September 2015
Revised: 22 October 2015
Accepted: 27 October 2015
First Online: 26 November 2015
Competing interests
: PDT has received research support from Genomas, Roche, Sanolfi, Regeneron, Esperion, Amarin and Pfizer; has served as a consultant for Amgen, Regeneron, Merck, Genomas, Runners World, Sanolfi, Esperion and Amarin; has received speaker honoraria from Merck, Astra Zenica, Kowa and Amarin; owns stock in Abbvie, Abbott Labs, General Electric, J&J; and has provided expert legal testimony on exercise-related cardiac events and statin myopathy. BAT served on the Pharmacovigilance Monitoring Board for Amgen, Inc. The remaining authors declare no conflict of interest.
Free to read: This content has been made available to all.
